Ahmed, A. T., Mahmoudian Dehkordi, S., Bhattacharyya, S., Arnold, M., Louie, G., Dunlop, B., … Kaddurah-Daouk, R. (2019). T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram Treatment. In Biological Psychiatry (Vol. 85, pp. S177–S178). Elsevier BV. https://doi.org/10.1016/j.biopsych.2019.03.449

Ahmed, Ahmed T., Siamak Mahmoudian Dehkordi, Sudeepa Bhattacharyya, Matthias Arnold, Gregory Louie, Boadie Dunlop, Liewei Wang, et al. “T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram Treatment.” In Biological Psychiatry, 85:S177–78. Elsevier BV, 2019. https://doi.org/10.1016/j.biopsych.2019.03.449.

Ahmed AT, Mahmoudian Dehkordi S, Bhattacharyya S, Arnold M, Louie G, Dunlop B, et al. T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram Treatment. In: Biological Psychiatry. Elsevier BV; 2019. p. S177–8.

Ahmed, Ahmed T., et al. “T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram Treatment.” Biological Psychiatry, vol. 85, no. 10, Elsevier BV, 2019, pp. S177–78. Crossref, doi:10.1016/j.biopsych.2019.03.449.

Ahmed AT, Mahmoudian Dehkordi S, Bhattacharyya S, Arnold M, Louie G, Dunlop B, Wang L, Weinshilboum R, Krishnan R, Bobo WV, Posse PR, Craighead WE, McDonald W, Skime MK, John Rush A, Frye MA, Kaddurah-Daouk R. T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram Treatment. Biological Psychiatry. Elsevier BV; 2019. p. S177–S178.